DL-Tetrahydropalmatine may act through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats

Neurosci Lett. 2001 Jul 20;307(3):163-6. doi: 10.1016/s0304-3940(01)01962-0.

Abstract

DL-Tetrahydropalmatine (THP), an active component isolated from corydalis (a Chinese herbal medicine), possesses analgesic effects. Systemic administration of picrotoxin (3-4 mg/kg) produced increases of locomotion (including horizontal motion, vertical motion, and total distance traveled), elevations of turnings (including both clockwise and anticlockwise), and inhibition of postural freezing in freely moving rats, and increases of amygdaloidal release of dopamine in anesthetizes rats. All the afore-mentioned activity measures induced by picrotoxin were suppressed following THP pretreatment. The results indicate that THP may act through inhibition of amygdaloid dopamine release to inhibit an epileptic attack.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amygdala / drug effects*
  • Amygdala / metabolism
  • Animals
  • Berberine Alkaloids / pharmacology*
  • Dopamine / metabolism*
  • Dopamine Antagonists / pharmacology*
  • Epilepsy / chemically induced
  • Epilepsy / drug therapy*
  • Epilepsy / physiopathology
  • GABA Antagonists / pharmacology
  • Hyperkinesis / chemically induced
  • Hyperkinesis / drug therapy
  • Hyperkinesis / physiopathology
  • Male
  • Motor Activity / drug effects
  • Motor Activity / physiology
  • Neural Inhibition / drug effects*
  • Neural Inhibition / physiology
  • Neurons / drug effects*
  • Neurons / metabolism
  • Picrotoxin / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • gamma-Aminobutyric Acid / metabolism

Substances

  • Berberine Alkaloids
  • Dopamine Antagonists
  • GABA Antagonists
  • Picrotoxin
  • tetrahydropalmatine
  • gamma-Aminobutyric Acid
  • Dopamine